Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Blue Origin launches New Glenn rocket on company's first NASA-scale science mission - 2‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
- 3He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- 4SF Chinatown's historic Empress of China building being revived into cultural campus
- 5'Outrageous and illegal' : UNRWA slams Israel for cutting off its water, comms and electric in Gaza
- Display of Netanyahu's severed head 'incites public to murder PM', Likud says in official complaint
- How grandchildren are stepping up to fill the caregiver gap
- Surge of off‑lease electric vehicles expected to drive down used EV prices
- Taste the World: Five Food sources That Have Dazzled Worldwide Palates
- What we know about the Brown University shooting suspect who was found dead, and how police linked him to the MIT killing
- Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
- Clocks to go forward one hour in Europe as summer time starts
- Don't plan to cook on Thanksgiving? Here are the restaurants and fast food places that are scheduled to be open
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
